Herein,
we subtly engineered a pH and membrane receptor dual-activatable
aptamer therapeutic for bispecific tumor cell imaging and in situ
drug release by utilizing a hairpin-contained i-motif as the acid-responsive
element to be complementary with a tumor-targeted aptamer, named as
an aptamer “molecule-doctor” (pH-Apt-MD). Specifically,
the pH-Apt-MD consisted of two DNA strands, where the Apt-sgc8c was
labeled with AF488 and Cy3 at its 5′- and 3′-end, respectively.
The I-strand, a hairpin-contained i-motif, was complementary to the
Apt-sgc8c strand partially, labeled with a BHQ2 in the middle, thus
generating Cy3 with quenched fluorescence and only AF488-emitted fluorescence.
The double-helix region of pH-Apt-MD was designed rich in GC bases,
providing sites for doxorubicin (Dox) intercalation. Once target cells
were encountered, the pH-Apt-MD disassembled due to the specific recognition
of the aptamer and conformation change of the i-motif, with activated
fluorescence resonance energy transfer (FRET) signals between AF488
and Cy3, accompanied by Dox release in situ. Benefiting from the design
of the hairpin-contained i-motif, the pH-Apt-MD presented a narrow
pH response range (pH 6.0–6.8) with a transition midpoint (pHT) of 6.50 ± 0.04. Furthermore, living cell studies revealed
that the stimuli-responsive FRET signal activation of pH-Apt-MD was
successfully achieved on the HCT116 cell surface with ultralow background
and enhanced imaging contrast. Then, the cytotoxicity experiments
proved that accurate drug release and cell killing were realized to
target cells in an acidic microenvironment. As a facile double stimuli-responsive
strategy, the pH-Apt-MD may hold great promise for application in
precise diagnosis and therapy of cancer cells.